- Home
- ALL vs COR Comparison
ALL vs COR Comparison
Compare ALL & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALL | COR |
|---|---|---|
| Founded | 1931 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.9B | 62.0B |
| IPO Year | 1996 | 2001 |
Fundamental Metrics
Financial Performance| Metric | ALL | COR |
|---|---|---|
| Price | $258.10 | $313.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 14 |
| Target Price | $226.65 | ★ $390.62 |
| AVG Volume (30 Days) | ★ 1.7M | 1.5M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.04% | 0.77% |
| EPS Growth | ★ 124.01 | 5.71 |
| EPS | ★ 21.73 | 15.21 |
| Revenue | $67,685,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | N/A | $8.89 |
| Revenue Next Year | $5.96 | $6.75 |
| P/E Ratio | ★ $11.77 | $20.66 |
| Revenue Growth | 5.58 | ★ 9.31 |
| 52 Week Low | $188.08 | $244.82 |
| 52 Week High | $277.22 | $377.54 |
Technical Indicators
Market Signals| Indicator | ALL | COR |
|---|---|---|
| Relative Strength Index (RSI) | 50.76 | 52.41 |
| Support Level | $255.11 | $298.65 |
| Resistance Level | $276.31 | $326.95 |
| Average True Range (ATR) | 6.69 | 8.10 |
| MACD | -1.98 | -0.48 |
| Stochastic Oscillator | 13.05 | 38.10 |
Price Performance
Historical ComparisonAbout ALL Allstate Corporation (The)
Allstate is one of the largest US property-casualty insurers in the US. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 6,000 exclusive agents.
About COR Cencora Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.